Po-Chang Shih

• Assistant Professor, Institute of BioPharmaceutical Sciences, College of Medicine, NSYSU, Taiwan, 2023/08 ~ now

• JSPS Postdoctoral Fellow, The University of Tokyo/ Japan Society for the Promotion of Science, 2022/04 ~ 2023/06 

• Postdoctoral Researcher, Kaohsiung Chang Gung Memorial Hospital, 2021/09 ~ 2022/04

• Postdoctoral Research Scientist, SyneuRx Lifesciences US Inc. & 心悅生醫股份有限公司, 2020/02~2021/08

June 2025

• NSYSU Academe Collaboration Incentives (New Faculty), Taiwan 

國立中山大學114學年度產學激勵 - 新秀類

March 2025

• NSYSU Excellent Teaching Awards, Taiwan 

國立中山大學113學年度第一學期教學優良課程 : 藥物開發通論、生技醫藥智財與法規

Dec. 2024

• 2024 NSYSU New Faculty Award, Taiwan 

國立中山大學113學年度新進教師獎勵

May 2024

• 2023 NSYSU New Faculty Award, Taiwan 

國立中山大學112學年度新進教師獎勵

Dec. 2021

• JSPS Postdoctoral Fellowship (Standard), Japan Society for the Promotion of Science, Japan 

日本學術振興協會JSPS Postdoctoral Fellowship (Standard)

March 2020

• Fellow of LEAP Program of Ministry of Science and Technology, Taiwan

台灣科技部博士創新計畫

April 2019

• UCL School of Pharmacy Best PhD Student Publication Award 2018, UK

Dec. 2016

• Poster Prize at 10th BMCS Biological and Medicinal Chemistry Postgraduate Symposium, UK

June 2014

• Honorary member of The Phi Tau Phi Scholastic Honor Society of Taiwan

中華民國斐陶斐榮譽會員

• THE INTELLECTUAL PROPERTY AND REGULATION IN BIOPHARMACEUTICALS 

• TOXIC RESPONSES OF ORGANS 

• DRUG METABOLISM AND PHARMACOKINETICS 

• TARGETED PROTEIN DEGRADATION BASED DRUG DEVELOPMENT（I）

• TARGETED PROTEIN DEGRADATION BASED DRUG DEVELOPMENT（II） 

• INDEPENDENT STUDIES IN BIFUNCTIONAL MOLECULE DRUG DISCOVERY（I） 

• INDEPENDENT STUDIES IN BIFUNCTIONAL MOLECULE DRUG DISCOVERY（II）